CardiAQ Valve Technologies presents at EuroPCR 2010
CardiAQ Valve Technologies (“CVT”) to disclose data during “EuroPCR 2010” about the world’s first successful...
Search for Articles
May 20, 2010
Jan 12, 2010
CardiAQ Valve Technologies closes $6.5M Series A
Transcatheter heart valve company CardiAQ Valve Technologies (CVT), which is developing the world’s first self-conforming...
Jun 9, 2009
miRagen Therapeutics, Inc. extends Series A to $12M
miRagen Therapeutics, Inc., a biopharmaceutical company focused on improving patients’ lives by developing innovative microRNA...
May 13, 2009
CardiAQ Valve Technologies receives seed funding from Broadview Ventures
CardiAQ Valve Technologies (CVT) received $750,000 in seed or ‘translational’ funding from Broadview Ventures Inc.—a...